Novo Nordisk A/S Operating Cycle 2011-2026 | NVO

Annual Operating Cycle Novo Nordisk A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	426	395	384	361	357	313	322	343

All numbers in DKK currency

Maximum	Minimum	Average
426	313	363

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
AbbVie ABBV	350	$ 212.08	0.45 %	$ 375 B	USA
AbCellera Biologics ABCL	173	$ 3.29	-1.94 %	$ 983 M	Canada
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	127	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Avid Bioservices CDMO	148	-	-	$ 789 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	107	$ 12.29	-11.96 %	$ 1.86 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	436	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Summit Therapeutics SMMT	379	$ 16.55	-4.11 %	$ 12.4 B	Britain
Alnylam Pharmaceuticals ALNY	102	$ 319.85	-2.53 %	$ 41.9 B	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.34	-2.47 %	$ 832 M	Canada
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Fusion Pharmaceuticals FUSN	6	-	-	$ 1.41 B	Canada